Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,612 | -62,995 | -38,982 | -19,909 | -81,047 |
| Depreciation Amortization | 909 | 661 | 419 | 203 | 634 |
| Income taxes - deferred | -3,162 | -2,511 | -593 | -340 | -991 |
| Accounts receivable | 296 | 142 | 180 | 31 | -357 |
| Accounts payable and accrued liabilities | 400 | -886 | -637 | -563 | -1,183 |
| Other Working Capital | 3,660 | 635 | 619 | 1,947 | -14,595 |
| Other Operating Activity | 12,233 | 11,042 | 6,707 | 3,660 | 21,799 |
| Operating Cash Flow | $-73,276 | $-53,912 | $-32,287 | $-14,971 | $-75,740 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,142 | -1,192 | -970 | -595 | -1,491 |
| Purchase Of Investment | -165,156 | -75,496 | -49,551 | -17,330 | -172,469 |
| Sale Of Investment | 190,385 | 142,708 | 79,293 | 37,056 | 211,734 |
| Investing Cash Flow | $23,087 | $66,020 | $28,772 | $19,131 | $37,774 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 34,693 | 34,693 | 9,835 | N/A | N/A |
| Common Stock Issued | 6,040 | 5,909 | 1,862 | 1,709 | 622 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -275 |
| Financing Cash Flow | $40,733 | $40,602 | $11,697 | $1,709 | $347 |
| Beginning Cash Position | 54,789 | 54,789 | 54,789 | 54,789 | 92,408 |
| End Cash Position | 45,333 | 107,499 | 62,971 | 60,658 | 54,789 |
| Net Cash Flow | $-9,456 | $52,710 | $8,182 | $5,869 | $-37,619 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,276 | -53,912 | -32,287 | -14,971 | -75,740 |
| Capital Expenditure | -2,142 | -1,192 | -970 | -595 | -1,491 |
| Free Cash Flow | -75,418 | -55,104 | -33,257 | -15,566 | -77,231 |